Urinary metabonomic study on colorectal cancer.
暂无分享,去创建一个
Tianlu Chen | Yan Ni | Wei Jia | Mingming Su | Lisa X Xu | Yunping Qiu | L. Xu | Ye Xu | W. Jia | M. Su | Y. Qiu | Tianlu Chen | Yan Ni | G. Cai | S. Cai | A. Zhao | Yu-min Liu | Aihua Zhao | Sanjun Cai | Ye Xu | Guoxiang Cai | Yumin Liu | Yunping Qiu
[1] R. Abagyan,et al. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.
[2] J. Collet,et al. Use of antidepressants and risk of colorectal cancer: a nested case-control study. , 2006, The Lancet. Oncology.
[3] Elaine Holmes,et al. Susceptibility of human metabolic phenotypes to dietary modulation. , 2006, Journal of proteome research.
[4] E. Holmes,et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. , 2008, Environmental microbiology.
[5] Stefano Tiziani,et al. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. , 2009, Neoplasia.
[6] A. Halabe Bucay. The biological significance of cancer: mitochondria as a cause of cancer and the inhibition of glycolysis with citrate as a cancer treatment. , 2007, Medical hypotheses.
[7] U. Günther,et al. Early Stage Diagnosis of Oral Cancer Using , 2009 .
[8] D. Funch. Predictors and Consequences of Symptom Reporting Behaviors in Colorectal Cancer Patients , 1988, Medical care.
[9] Kyoungmi Kim,et al. Urine Metabolomics Analysis for Kidney Cancer Detection and Biomarker Discovery*S , 2009, Molecular & Cellular Proteomics.
[10] Rachel Cavill,et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). , 2009, Journal of proteome research.
[11] Minjun Chen,et al. Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling. , 2007, Analytica chimica acta.
[12] M. Pincus,et al. Regulation of JNK signaling by GSTp , 1999, The EMBO journal.
[13] C. Hew,et al. Proteomic Analysis of Colorectal Cancer Reveals Alterations in Metabolic Pathways , 2006, Molecular & Cellular Proteomics.
[14] J. Heddle,et al. The potent colon carcinogen, 1,2-dimethylhydrazine induces mutations primarily in the colon. , 2004, Mutation research.
[15] E. Gerner,et al. Polyamine-mediated post-transcriptional regulation of COX-2. , 2002, Biochimie.
[16] R P Bird,et al. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. , 1995, Cancer letters.
[17] Z. Bentwich,et al. Carcinoembryonic Antigen , 1978 .
[18] W. Leung,et al. Increasing incidence of colorectal cancer in Asia: implications for screening. , 2005, The Lancet. Oncology.
[19] D. Salvadori,et al. DNA damage and aberrant crypt foci as putative biomarkers to evaluate the chemopreventive effect of annatto (Bixa orellana L.) in rat colon carcinogenesis. , 2005, Mutation research.
[20] A. Zauber,et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .
[21] T. Selmer,et al. p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. A novel glycyl radical enzyme catalysing the formation of p-cresol. , 2001, European journal of biochemistry.
[22] L M Schuman,et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.
[23] C. Vara-Thorbeck,et al. Increased histidine decarboxylase (HDC) activity in human colorectal cancer: Results of a study on ten patients , 1988, Agents and Actions.
[24] D. Barkla,et al. Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. , 1982, British Journal of Cancer.
[25] Tianlu Chen,et al. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. , 2009, Journal of proteome research.
[26] G. Rechkemmer,et al. Protective role of probiotics and prebiotics in colon cancer. , 2001, The American journal of clinical nutrition.
[27] O. Fiehn,et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. , 2006, Cancer research.
[28] A. Imperiale,et al. Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy , 2009, Metabolomics.
[29] R P Bird,et al. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. , 1987, Cancer letters.
[30] C. Rice-Evans,et al. Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. , 2004, Free radical biology & medicine.
[31] S. Elsden,et al. The end products of the metabolism of aromatic amino acids by clostridia , 1976, Archives of Microbiology.
[32] J. Olsen,et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.
[33] Oliver Fiehn,et al. Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover , 2008, Molecular Cancer.
[34] C. Wolf,et al. Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. , 1990, Carcinogenesis.
[35] G. Balendiran,et al. The role of glutathione in cancer , 2004, Cell biochemistry and function.